Search

everythinglearnresearchcommunity

for

Search:↓

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Anti-CD19 therapy may help treat SLE and NMOSD.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Anti-angiogenic therapy can help treat cancer but may cause resistance and side effects, so alternative methods are being explored.

Bevacizumab may worsen hypothyroidism, so thyroid function should be monitored during treatment.

Methotrexate is a key, cost-effective drug for skin conditions, but requires careful monitoring for side effects.

Tofacitinib is a promising treatment for children with rheumatic diseases.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

Developing microRNA-based treatments is hard but has potential.

A woman with advanced eye cancer went into complete remission using a combination of immunotherapy and topical treatments.

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

Effective management of side effects is crucial for safe use of sacituzumab govitecan in advanced breast cancer treatment.

Cell extracts may effectively and safely repair radiation-damaged salivary glands.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Some alternative treatments for vitiligo show promise but need more research to confirm their safety and effectiveness.

ICI therapy increases the risk of gastrointestinal and endocrine issues in psoriasis patients.

Nanocarriers can improve skin treatments after cancer therapy by enhancing antioxidant delivery and effectiveness.

Monitor for early signs of azathioprine toxicity and check blood counts regularly.

New treatments for a type of skin cancer show promise but have side effects and may work better with other therapies.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Immunosuppression therapy with methylprednisolone effectively treats childhood alopecia areata.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Blood pressure drugs can cause skin lupus, but it improves after stopping the drug. The glycoprotein D vaccine works against genital herpes in some women, and the HPV-16 vaccine reduces HPV-16 infection and related diseases. More frequent light therapy clears psoriasis faster. A cream called imiquimod effectively treats a type of skin cancer. Iron supplements don't necessarily help with chronic hair loss in women.

Cytokine therapy is promising for treating skin conditions like vitiligo and psoriasis.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.